<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01565512</url>
  </required_header>
  <id_info>
    <org_study_id>AAAI5060</org_study_id>
    <nct_id>NCT01565512</nct_id>
  </id_info>
  <brief_title>Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomfort</brief_title>
  <official_title>Randomized Trial to Determine the Effect of Dorsal Penile Block on Post-Robotic Prostatectomy Foley Discomfort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The indwelling urethral foley is a major source of discomfort following radical
      prostatectomy. Our hypothesis is that intra-operative dorsal penile nerve block with
      bupivacaine may decrease immediate post-operative foley discomfort.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing robot-assisted radical prostatectomy (RARP) will be randomized in a
      double-blind placebo controlled manner to undergo penile ring block injection at the time of
      skin incision closure. A visual analog scale (VAS) based questionnaire including newly
      developed foley discomfort scores will be administered at various time points
      post-operatively.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Lack of funding, PI left the institution, poor enrollment
  </why_stopped>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of pain/discomfort</measure>
    <time_frame>postoperative</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Prostate Cancer</condition>
  <condition>Robotic Prostatectomy</condition>
  <condition>Foley Catheter Discomfort</condition>
  <arm_group>
    <arm_group_label>saline injection</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>saline injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>penile block with bupivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>A total of 100 mg bupivacaine (20 mL of 5 mg/mL solution) administered once by subcutaneous injection while patient is under general anesthesia at end of operation.</description>
    <arm_group_label>Bupivacaine injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>A total of 20 mL on injectable saline(0.9% NS) administered once by subcutaneous injection while patient is under general anesthesia at end of operation.</description>
    <arm_group_label>saline injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 40 years and above,

          -  diagnosis of prostate cancer,

          -  electing to undergo robot-assisted radical prostatectomy

        Exclusion Criteria:

          -  allergy to bupivacaine or amide-type local anesthetics,

          -  chronic pain condition,

          -  recently or currently on narcotics,

          -  genital abnormalities
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ketan K. Badani, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor, Department of Urology, New York Presbyterian Hospital, Columbia University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chris O. Wambi, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Urology, New York Presbyterian Hospital, Columbia University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mitchell C. Benson, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Professor and Chairman, Department of Urology, New York Presbyterian Hospital, Columbia University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York Presbyterian Hospital/Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2012</study_first_submitted>
  <study_first_submitted_qc>March 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2012</study_first_posted>
  <last_update_submitted>March 3, 2015</last_update_submitted>
  <last_update_submitted_qc>March 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>randomized trial</keyword>
  <keyword>robotic prostatectomy</keyword>
  <keyword>prostate cancer</keyword>
  <keyword>foley catheter discomfort</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

